| 000 | 01559 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517221253.0 | ||
| 264 | 0 | _c20190228 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1744-8298 | ||
| 024 | 7 |
_a10.2217/fca-2018-0026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPimentel Quezada, Yesenia | |
| 245 | 0 | 0 |
_aHas the clinical profile of patients with nonvalvular atrial fibrillation treated with rivaroxaban changed in the last 5 years of use? _h[electronic resource] |
| 260 |
_bFuture cardiology _c05 2018 |
||
| 300 |
_a47-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
| 650 | 0 | 4 |
_aFactor Xa Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPractice Patterns, Physicians' |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRivaroxaban _xtherapeutic use |
| 650 | 0 | 4 |
_aStroke _xetiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBonilla Palomas, Juan Luis | |
| 700 | 1 | _aGámez López, Antonio Luis | |
| 700 | 1 | _aMoreno Conde, Mirian | |
| 700 | 1 | _aLópez Ibáñez, María Cristina | |
| 700 | 1 | _aGallego de la Sacristana López-Serrano, Ángel | |
| 773 | 0 |
_tFuture cardiology _gvol. 14 _gno. 3s _gp. 47-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/fca-2018-0026 _zAvailable from publisher's website |
| 999 |
_c28476842 _d28476842 |
||